Physician profile
Lee Miesner
NPI 1942705470
$4,774.99
in general payments reported to CMS, 2019-2025
17 companies · $2,687 in 2025
The $2,687 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,448 · 2023: $431 · 2024: $209 · 2025: $2,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,956 · Food and Beverage: $1,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,955.59 |
| Food and Beverage | $1,371.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,468.67 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Stryker Corporation | $1,385.56 | 2025 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $151.00 | 2023 | Relistor |
| Globus Medical, INC. | $149.97 | 2025 | Senza |
| Zynex Medical, INC. | $145.92 | 2023 | Nexwave |
| Spr Therapeutics, INC | $122.67 | 2022 | |
| Boston Scientific Corporation | $77.95 | 2022-2023 | Superion Indirect Decompression System |
| Merck Sharp & Dohme LLC | $63.40 | 2024 | Bridion |
| Curonix LLC | $36.53 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $34.26 | 2023 | Xtampza, Belbuca |
| Virtus Pharmaceuticals LLC | $23.53 | 2023 | Levorphanol Tartrate |
| Ibsa Pharma INC. | $22.23 | 2023 | Tirosint, Licart |
| Hikma Pharmaceuticals USA | $21.07 | 2022 | |
| Heron Therapeutics, INC. | $19.85 | 2025 | Zynrelef |
| Scilex Pharmaceuticals INC. | $18.65 | 2023 | Ztlido |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $17.02 | 2025 | Cygnus Dual |
| Nevro Corp. | $16.71 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Miesner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.